2022 (v1)
Publication
No description
Uploaded on: September 3, 2024
-
-
2023 (v1)Publication
No description
Uploaded on: August 30, 2024 -
2023 (v1)Publication
No description
Uploaded on: August 30, 2024 -
2022 (v1)Publication
Cannabidiol (CBD) exhibits anti-inflammatory, anxiolytic, antiseizure, and neuroprotective proprieties without addictive or psychotropic side effects, as opposed to Δ9-tetrahydrocannabinol (THC). While recreational cannabis contains higher THC and lower CBD concentrations, medical cannabis contains THC and CBD in different ratios, along with...
Uploaded on: February 4, 2024 -
2021 (v1)Publication
Adenosine Deaminase 2 Deficiency (DADA2) (OMIM: 607575) is a monogenic, autoin-flammatory disease caused by the loss of functional homozygous or heterozygous mutations in the ADA 2 gene (previously CECR1, Cat Eye Syndrome Chromosome Region 1). A timely diagnosis is crucial to start Anti-TNF therapies that are efficacious in controlling the...
Uploaded on: April 14, 2023 -
2021 (v1)Publication
Cannabidiol (CBD) is a promising therapeutic agent with analgesic, myorelaxant, and anti-epileptic actions. Recently, a purified form of CBD (Epidiolex®) has been approved by the Eu-ropean Medicines Agency (EMA) for the treatment of two highly-refractory childhood-onset epi-lepsies (Dravet and Lennox-Gastaut syndrome). Given the interindividual...
Uploaded on: April 14, 2023